Abbvie seeks to block copycat of endometriosis drug

04-04-2023

Liz Hockley

Abbvie seeks to block copycat of endometriosis drug

Piotr Swat / Shutterstock.com

Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January.


Teva, Abbvie, patent, Orilissa, ANDA, generic, endometriosis, treatment, infringes, copycat, medication, lawsuit, product, injunction, claims, copy

LSIPR